Akcea Therapeutics (AKCA), Ionis (IONS) Announce BROADEN Study with WAYLIVRA in Patients with FPL Met its Primary Endpoint

August 6, 2019 5:14 PM

Akcea Therapeutics, Inc. (NASDAQ: AKCA), an affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), announced today topline ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found